Sucroferric oxyhydroxide (sucroferric oxyhydroxide)

Approved for Velphoro is indicated for the control of serum phosphorus levels in adults and pediatric patients 9 years of age and older with chronic kidney disease (CKD) on dialysis.. In the aqueous environment of the GI tract, phosphate binding takes place by ligand exchange between hydroxyl groups and/or water in sucroferric oxyhydroxide and the phosphate in the diet. The bound… Side effects,…

Loading full data from Know Your Drugs Institute…